Guy Harmelin
InvestorChief Investment Officer, Advanced Technology at MGX
Find your path to Guy
Sign up to see every warm intro you have to Guy
- Paths you didn't know you had: your email and LinkedIn already hold routes to Guy. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Dr. Guy Harmelin is a physician-turned-investor and serial biotech founder (RondinX/BiomX NYSE; Ayala Pharmaceuticals Nasdaq) with Oxford Nanopore board experience and a $750K–$10M life sciences and industrials investment focus.
Invests in
AI & Machine LearningBiotechData & InfrastructureRoboticsSemiconductors
Colleagues at MGX
Frequently asked questions
- Who is Guy Harmelin?
- Dr. Guy Harmelin is a physician-turned-investor and serial biotech founder (RondinX/BiomX NYSE; Ayala Pharmaceuticals Nasdaq) with Oxford Nanopore board experience and a $750K–$10M life sciences and industrials investment focus.
- Where does Guy Harmelin work?
- Guy Harmelin is Chief Investment Officer, Advanced Technology at MGX.
- What does Guy Harmelin invest in?
- Guy Harmelin invests in AI & Machine Learning, Biotech, Data & Infrastructure, Robotics, Semiconductors.
About this profile. Compiled from public sources — MGX's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights




